All In Biotech

Drug Trial Radar · NCT06194461

LTFU for All Cell and Gene Therapy Studies

A LOng-term Follow-up Master Protocol for Participants Who Received Cell or Gene Therapies in Other AstraZeneca StUdieS (LOCUS)

Last checked: Nov 19, 2026Latest source record: Jun 27, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

64

Planned (sponsor's estimate)

Start

Sep 17, 2025

Primary completion

Nov 29, 2041

Study completion Nov 29, 2041

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Jan 8, 2024

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 130 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Master LTFU study will monitor the long-term safety and tolerability of cell or gene therapy study participants from AstraZeneca for up to 15 years post last cell or gene therapy treatment.

Conditions

  • Hepatocellular Carcinoma
  • Prostate Cancer

Interventions

  • AZD5851Biological

    Safety follow-up for up to 15 years of subjects who received AZD5851 in study NCT06084884.

  • AZD0754Biological

    Safety follow-up for up to 15 years of subjects who received AZD0754 in study NCT06267729.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of specific AEsTime frame: Maximum of 15 years post dosing

Locations

25 sites in 4 countries. Site status is shown where the registry gives one.

  • Research Site

    Phoenix, Arizona

  • Research Site

    Duarte, California

  • Research Site

    Orange, California

  • Research Site

    San Francisco, California

  • Research Site

    Washington D.C., District of Columbia

  • Research Site

    Jacksonville, Florida

  • Research Site

    Tampa, Florida

  • Research Site

    Atlanta, Georgia

  • Research Site

    Westwood, Kansas

  • Research Site

    Rochester, Minnesota

  • Research Site

    St Louis, Missouri

  • Research Site

    Hackensack, New Jersey

  • Research Site

    New York, New York

  • Research Site

    Columbus, Ohio

  • Research Site

    Portland, Oregon

  • Research Site

    Philadelphia, Pennsylvania

  • Research Site

    Pittsburgh, Pennsylvania

  • Research Site

    Houston, Texas

  • Research Site

    East Melbourne, Australia

  • Research Site

    Kashiwa, Japan

  • Research Site

    Kyoto, Japan

  • Research Site

    Osakasayama-shi, Japan

  • Research Site

    Seoul, South Korea

  • Research Site

    Seoul, South Korea

  • Research Site

    Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.